Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Nephrolithiasis
ADR ID BADD_A03021
ADR Hierarchy
20      Renal and urinary disorders
20.04      Urolithiases
20.04.01      Renal lithiasis
20.04.01.002      Nephrolithiasis
Description Formation of stones in the KIDNEY. [MeSH]
MedDRA Code 10029148
MeSH ID D053040; D007669
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Calculus kidney | Calculus of kidney | Calculus of kidney and ureter | Calculus renal | Calculus renal NOS | Crystallization kidney | Kidney calculus | Kidney crystallisation | Kidney stone | Kidney stones | Nephrolithiasis | Renal calculi | Renal calculus | Renal calculus NOS | Renal stone | Uric acid nephrolithiasis | Unilateral renal calculus | Kidney crystallization | Crystallisation kidney | Renal pelvic calcification | Nephrolithiasis recurrent | Gouty diathesis | Ureteropelvic junction stone | Renal microlithiasis | Bilateral nephrolithiasis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02234Tocilizumab--
BADD_D02236Tofacitinib0.020856%
BADD_D02241Tolcapone--
BADD_D02246Tolvaptan--
BADD_D02247Topiramate0.002830%
BADD_D02254Tramadol--
BADD_D02257Trametinib0.000112%
BADD_D02265Travoprost0.000184%
BADD_D02275Triamterene--
BADD_D02276Triamterene hydrochlorothiazide--
BADD_D02319Urofollitropin--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000185%
BADD_D02334Vandetanib--
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02346Venlafaxine--
BADD_D02355Vigabatrin0.000311%
BADD_D02371Vortioxetine0.000444%
BADD_D02373Warfarin--
BADD_D02375Water--
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02392Zoledronic acid--
BADD_D02396Zonisamide0.002900%
BADD_D02407Upadacitinib0.003520%
BADD_D02412Octreotide0.001025%
BADD_D02428Loperamide--
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.006100%
The 9th Page    First    Pre   9 10    Next   Last    Total 10 Pages